In summary, the current study demonstrates LETMD1 as a pivotal player in enhancing non-canonical, UCP1-independent energy expenditure in human beige adipocytes, and therefore establishes it as a druggable target for obesity and metabolic diseases. The gene discussed is LETMD1; the disease is obesity due to melanocortin 4 receptor deficiency.